Latest Headlines

Latest Headlines

CHMP recommends approval of a host of new drugs

Some big news has come out of a key advisory committee for European drug approvals. In addition to backing approval of Merck's ($MRK) hepatitis C drug Victrelis (boceprevir), European Medicines

Blockbuster antibodies face a unique set of challenges

When Bristol-Myers Squibb's Yervoy recently won approval from the FDA, the analysts at Deloitte Recap chalked that up as the 25th such regulatory milestone for a monoclonal antibody credited to a

With $120K price tag, Yervoy hailed as potential blockbuster

Bristol-Myers Squibb's ($BMS) newly approved melanoma drug illustrates a few things about today's pharma industry. For instance, that Big Pharma can still manage to develop breakthrough new drugs,

FDA hands Bristol a blockbuster approval for breakthrough cancer drug

By the time the dust had settled on Friday's announcement that the FDA had approved Yervoy (ipilimumab) for melanoma, analysts were left clearly impressed by two key points: The FDA had extended an

FDA approves Bristol's Yervoy (ipilimumab) for melanoma

The FDA has approved Bristol-Myers Squibb's Yervoy (ipilimumab), a closely-watched new drug for advanced melanoma. The FDA delayed a decision on the drug in November after BMS submitted further